Sepsis & infection

Development and validation of a nomogram prediction model for surgical site infection after instrumentation for degenerative lumbar spinal diseases

Perioper Med (Lond)Published Retrospective cohort study

Authors' conclusion

This study found a moderate 3.5% SSI rate following instrumentation for degenerative lumbar spinal diseases and identified several risk factors.

Study context

Population
Patients undergoing posterior instrumentation for degenerative lumbar spinal diseases, January 2020–December 2022, minimum 12-month follow-up687 men · 775 women
Participants
1,462 patients
Exposure
Surgical site infection (SSI) vs no SSI
Outcome
Incidence and risk factors for SSI
Methodological detailsprediction model development and validation, multivariate logistic regression, nomogram, bootstrap validation
  • Prediction model development and validation
  • Multivariate logistic regression
  • Nomogram
  • Bootstrap validation

Main finding

As reported in the abstract

SSI incidence and independent risk factors
SSI incidence (53 patients)
3.5%
ASA class III or IV vs I or II, OR
2.362 (95% CI 1.312 to 4.249)
Surgery involving sacral vertebrae, OR
2.319 (95% CI 1.242 to 4.330)
Open vs minimally invasive surgery, OR
3.081 (95% CI 1.701 to 5.581)
Prolonged surgical time, per hour increase, OR
1.482 (95% CI 1.017 to 2.160)
Preoperative hemoglobin < 100 g/L, OR
4.962 (95% CI 1.728 to 6.943)

Observational data: associations, not effects.

Further findings

Nomogram discrimination (C-index)

C-index
0.743 (95% CI 0.682-0.804)
C-index after 1,000 bootstrap verifications
0.722
Calibration curve: predicted SSI probability aligned well with actual probability

Original publication

Development and validation of a nomogram prediction model for surgical site infection after instrumentation for degenerative lumbar spinal diseases. Perioper Med (Lond). Published 7 July 2025. doi:10.1186/s13741-025-00556-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.